More than 90% of patients with PsA who received guselkumab every 8 weeks in the DISCOVER-2 trial maintained minimal ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

Data from the Cohort of Cardiovascular Diseases in Pregnancy (CONCEPTION), a French prospective national cohort study, ...

Pediatric MG is rare. Cases in children are estimated to account for 10% of MG cases diagnosed each year. According to a 2020 ...

Up to 100% of ritlecitinib responders sustained hair regrowth and 30% of nonresponders achieved results at week 48 with ...

The findings suggested that higher doses of vitamin D3 supplementation do not reduce markers of subclinical cardiovascular ...

A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Weiss highlighted a 2012 Cochrane Library review that examined research and found the drug is “reasonably safe” and prolongs ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing could potentially match ...

COPD is a known risk factor for PE. To estimate how the obstructive lung disease may contribute to PE-related deaths among ...

Physicians consider a patient’s overall health, how much weight needs to be lost, and potential side effects in making a ...